Augusta, GA, United States of America

Willam Shelley Dynan

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Willam Shelley Dynan. Retrieved from https://idiyas.com/inventor/willam-shelley-dynan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Willam Shelley Dynan

Introduction

Willam Shelley Dynan is an accomplished inventor based in Augusta, GA. He has made significant strides in the field of cancer detection through his innovative methods. His work focuses on the over-expression of galectin-3, a biomarker associated with cancer.

Latest Patents

Dynan holds a patent for "Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3." This patent describes sensitive methods for determining if a subject has cancer. The methods generally involve quantifying the amount of one or more biomarkers derived from galectin-3 in a biological sample from the subject by mass spectrometry. An increase in the amount of one or more biomarkers in the biological sample, as compared to a control, indicates the presence of cancer in the subject.

Career Highlights

Throughout his career, Dynan has demonstrated a commitment to advancing medical technology. His innovative approach to cancer detection has the potential to improve early diagnosis and treatment options for patients. His work exemplifies the intersection of science and technology in addressing critical health challenges.

Collaborations

Dynan has collaborated with notable professionals in his field, including Paul M Weinberger and John Matthew Koomen. These collaborations have contributed to the development and refinement of his patented methods, enhancing their effectiveness and applicability in clinical settings.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…